Monoclonal Antibody Therapies and Neurologic DisordersArch Neurol 65:1162-1165, Novack,J.C.,et al., 2008
Daclizumab Phase II Trial in Relapsing and Remitting Multiple SclerosisNeurol 69:785-789, Rose,J.W.,et al, 2007